Medical Nitrous Oxide Market worth $2.8 billion by 2029

As per the recently published report by MarketsandMarkets™, The report “Medical Nitrous Oxide Market by Product (Gas, Liquid), Application (Anaesthesia, Pain, Cryosurgery, Surgical Insufflation), End User (Hospital, Home Healthcare, Academic, Research Institution), Key Stakeholder & Buying Criteria – Global Forecast to 2029″, size is estimated to be USD 2.8 billion by 2029 from USD 1.8 billion in 2023, at a CAGR of 6.6%.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=24902090
 
Browse.

  • 110     Market Data Tables
  • 55      Figures
  • 220     Pages and in-depth TOC on “Medical Nitrous Oxide Market – Global Forecast to 2029”

Some of the prominent key players are:

  • Messer SE & CO. KGAA (Germany),
  • SOL SpA (Italy),
  • Ellenbarrie Industrial Gases (India),
  • Norco Inc. (US),
  • Carbide and Chemicals (India), and many more……

Mergers & acquisitions, investments & expansions, partnerships & collaborations, and new product developments are some of the major strategies adopted by these key players to enhance their positions in the Medical Nitrous Oxide Market.

Driver: Improvements in healthcare infrastructure

Enhancements in healthcare infrastructure serve as a catalyst for the growth of the market. The continuous improvement and development of healthcare facilities contribute significantly to the increased demand for medical nitrous oxide. This is attributed to the heightened capability of upgraded healthcare infrastructure to support advanced medical procedures, including surgeries and pain management, wherein nitrous oxide plays a crucial role. As healthcare systems evolve and modernize, the demand for medical nitrous oxide is expected to rise proportionately, aligning with the evolving needs and standards of sophisticated healthcare delivery.

Opportunity: Growing demand for pain management

The increasing demand for pain management presents a significant opportunity for the market. As the need for effective and non-invasive pain relief methods continues to grow, medical nitrous oxide stands poised to capitalize on this trend. The unique analgesic properties of nitrous oxide make it a valuable asset in pain management within healthcare settings. This rising demand positions medical nitrous oxide as a preferred choice for healthcare professionals seeking efficient solutions for pain relief, thereby contributing to the expansion and opportunities within the market.

Market Segmentation: –

  • By product, the global medical nitrous oxide market is categorized into liquid state and gaseous state. The gaseous segment is expected to register the highest growth of the medical nitrous oxide market in 2023.
  • By application, the global medical nitrous oxide market is categorized into anaesthesia and pain relief, cryosurgery, and surgical insufflation. The anaesthesia and pain relief segment held the largest share of the market in 2023. Primarily attributed to the factors such as synergistic effects as nitrous oxide, when used alongside traditional anesthetics, amplifies their pain-relieving and anxiety-reducing properties.
  • Based on end user, the medical nitrous oxide market is categorized into hospitals, home healthcare, and academic and research institutions. The hospitals segment held the largest share of the medical nitrous oxide market in 2023.
  • Based on the region, the global medical nitrous oxide market is divided into North America, Europe, the Asia Pacific, Latin America, and Middle East & Africa. North America held the largest share of the global medical nitrous oxide market in 2023, while the Asia Pacific is projected to be the fastest-growing region in the forecast period.

Recent Developments of Medical Nitrous Oxide Industry:

  • In December 2023, Linde Healthcare has partnered with the Air Force Materiel Command to supply liquid oxygen and nitrogen to healthcare, manufacturing, metals, and mining.
  • In July 2023, Air liquid started a project to transform the Home Healthcare activity in France to align it with the needs and expectations of patients and healthcare professionals and adapt its business model to meet the challenges of the country’s healthcare system.

The primary impetus behind the medical nitrous oxide market stems from various factors, including the expanding elderly population, improvements in healthcare infrastructure, the desire for non-invasive pain relief methods, and the presence of supportive regulations and standards governing the utilization of medical gases. Furthermore, the escalating volume of surgical procedures, observed in both developed and developing nations, creates a favorable prospect for the heightened adoption of medical nitrous oxide in anesthesia and analgesia, presenting additional avenues for industry expansion.